Kevin Bruce Johnson serves as Executive at Tourmaline Bio, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Bruce Johnson has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 28, 2025 involved selling 11,046 shares valued at $0.
Kevin Bruce Johnson currently holds 11,046 shares of Tourmaline Bio, Inc. (TRML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Bruce Johnson has been a net neutral trader of TRML stock. They have purchased $0 and sold $0 worth of shares.
Kevin Bruce Johnson's most recent insider trade was on Oct 28, 2025, when they sold 11,046 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 15, 2025 | TRML | $0 | Gift | 6,250 | $N/A | Discretionary |
| Oct 19, 2023 | TRML | $0 | Award | 57,834 | $N/A | Discretionary |